SCHEMBL1508512

SCHEMBL1508512

OCC[C@H](O)c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
CYP1A2 P05177 1/20 0.56
PTGS1 P23219 1/20 0.56
SLC6A2 P23975 1/20 0.56
CYP2C19 P33261 1/20 0.56
PTGS2 P35354 1/20 0.56
SLC6A3 Q01959 1/20 0.56
HIF1A Q16665 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
LTA4H P09960 1/20 0.55
EPHX2 P34913 1/20 0.55
ALOX5 P09917 1/20 0.51
MAPT P10636 2/20 0.50
GAA P10253 2/20 0.50
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5852441 0.87 LMNA (0.59) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL9577515 0.83 CYP4F2 (0.59) LMNAALOX5NR4A2MAOBSMN1; SMN2
SCHEMBL8149319 0.83 ALOX5 (0.57) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL6190389 0.82 LMNA (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8482579 0.82 LMNA (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8481818 0.82 LMNA (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL322826 0.82 LMNA (0.58) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8483093 0.82 LMNA (0.50) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL3239740 0.81 LMNA (0.66) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL8761083 0.81 LMNA (0.66) LMNACYP1A2PTGS1SLC6A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289868-B1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO CO LTD (JP) 2014-08-13 EP disclosed
US-8222281-B2 Carboxylic acid compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-07-17 US disclosed
US-20110053974-A1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-03-03 US disclosed
EP-2289868-A1 CARBOXYLIC ACID COMPOUND Daiichi Sankyo Company, Limited (JP) 2011-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053974-A1 CARBOXYLIC ACID COMPOUND AKR1C3, SLC5A1, GPR119 LMNA 2035/4885CYP1A2 605/4885PTGS1 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.